Literature DB >> 5059112

Hypertension following 10 per cent phenylephrine ophthalmic.

D Solosko, R B Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5059112     DOI： 10.1097/00000542-197202000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  6 in total

Review 1.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 2.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 3.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 4.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

5.  Severe hypertension and pulmonary edema associated with systemic absorption of topical phenylephrine in a child during retinal surgery.

Authors:  Ashraf A Abdelhalim; Mohamed Mostafa; Ahmed Abdulmomen; Essam A Othman
Journal:  Saudi J Anaesth       Date:  2012-07

Review 6.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.